39 results
10-K
2023 FY
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
cybersecurity auditors are being considered for future engagement, at which point any risks stemming from the use of third parties will be incorporated … as part of the engagement process. The Company has monitoring procedures in place to identify and follow up on any overdue debts. Credit risk from
DEF 14A
TCBP
TC BioPharm (Holdings) plc
20 Feb 24
Definitive proxy
6:05am
with the solicitation process, for which we will bear the costs of any such engagement. The initial solicitation of proxies may be supplemented
PRE 14A
TCBP
TC BioPharm (Holdings) plc
9 Feb 24
Preliminary proxy
3:26pm
us with the solicitation process, for which we will bear the costs of any such engagement. The initial solicitation of proxies may be supplemented
6-K
TCBP
TC BioPharm (Holdings) plc
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
, 2023) per ADS.
The Company also entered into a letter agreement (the “Engagement Agreement”) with H.C. Wainwright & Co., LLC (the “Placement Agent
6-K
EX-10.3
yge10q68dp
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
424B4
vdv 9q2ola
20 Dec 23
Prospectus supplement with pricing info
6:42pm
F-1/A
vewqbxb5rd ov
14 Dec 23
Registration statement (foreign) (amended)
5:20pm
F-1/A
ealj0ckc
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
F-1/A
EX-4.21
7bpk0z9rlgpn
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
424B3
emnvp
8 Nov 23
Prospectus supplement
4:05pm
F-3/A
xz1akh avqf6qig2sw
2 Nov 23
Shelf registration (foreign) (amended)
1:11pm
6-K
EX-99.1
fhe65n mj2raacm11v5
2 Nov 23
Current report (foreign)
12:57pm
F-3
EX-5.2
91ywkc2iq4na3jlbew
29 Sep 23
Shelf registration (foreign)
4:05pm
F-3
4er8k9qw1sfi313kebv
29 Sep 23
Shelf registration (foreign)
4:05pm
F-1
tacnijlf37391638sui
28 Aug 23
Registration statement (foreign)
5:25pm
6-K
EX-99.1
wy1us124hwgcr r1p0gx
7 Jun 23
Current report (foreign)
4:10pm
6-K
EX-10.3
0xar5z q4
30 Mar 23
TC BioPharm Announces Pricing of $5.5 Million Public Offering
5:10pm
6-K
o9mjx5i8nqn
30 Mar 23
TC BioPharm Announces Pricing of $5.5 Million Public Offering
5:10pm